Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Pediatric Surgery|November 21, 2007
Familial extrarenal Wilms tumorChris H Houben, Joanna H Tong, Anthony W Chan, et al.
Cancer Research and Treatment|August 24, 2018
The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer SubtypesXingen Wang, Julia Y S Tsang, Michelle A Lee, et al.
BMC Cancer|June 8, 2010
Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinomaJoanna H Tong, David C Ng, Shuk L Chau, et al.
Cancer Research|April 26, 2019
TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin SignalingHongyan Gou, Jessie Qiaoyi Liang, Lijing Zhang, et al.
Gastroenterology|July 25, 2016
SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of AspartateChi Chun Wong, Yun Qian, Xiaona Li, et al.
Cancer Research|April 23, 2011
EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesisAlfred S L Cheng, Suki S Lau, Yangchao Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 13, 2019
The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the LungAnthony W Chan, Shuk L Chau, Joanna H Tong, et al.
Asia-Pacific Journal of Clinical Oncology|April 14, 2015
Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancerBrigette B Ma, Frankie Mo, Joanna H Tong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2016
MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor PrognosisJoanna H Tong, Sai F Yeung, Anthony W H Chan, et al.
Gut|September 24, 2017
Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacyJingying Zhou, Man Liu, Hanyong Sun, et al.
Pageof 2